Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon-like peptide 1 (GLP-1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits

K. Y. Thong, R. E. J. Ryder, M. L. Cull and C. Walton

Diabetic Medicine 29 ( 5 ): 690 - 692 , 2012